Increased incidence of cancer at various sites is observed in patients with end-stage renal
disease (ESRD). In particular, lymphomas and carcinomas of the kidney, prostate, liver and …

There is a well known association between end stage renal disease and the development of
kidney cancer in the native kidney of patients requiring renal replacement therapy. There is …

The evidence indicates an increased prevalence and likely also an increased incidence of
both renal and extrarenal malignancy in ESRD patients. With the exception of nonHodgkin's …

Objectives. This review was undertaken to determine the clinical significanceof renal cell
carcinoma in the populations undergoing renal transplantation and those undergoing …

Patients with chronic renal failure (CRF) have a high incidence of malignant tumours.
Uremia thus induces a remarkable suppression of immune status. In this study, we report …

The kidney may be involved in patients with malignancy for a variety of reasons. It may be
the site of a primary tumour or less commonly a secondary tumour. Furthermore, tumours …

Longer and better survival of End‐Stage Renal Disease (ESRD) patients undergoing renal
replacement therapy (RRT) is now associated with a higher prevalence of new elderly …

Some tumors are known to have a definite cause‐effect etiology, but renal cell carcinoma
(RCC) is not one of them precisely. With regard to RCC we can only try to identify some …

Various renal complications occur during the course of neoplastic disease. The therapeutic
and prognostic implications differ according to the reversibility of both the underlying …

Cancer incidence was assessed in 4,161 end-stage renal disease (ESRD) patients on
dialysis to determine whether there was any excess risk of cancer in this population …